Skip to Content
Merck
  • Multilayered textile coating based on a β-cyclodextrin polyelectrolyte for the controlled release of drugs.

Multilayered textile coating based on a β-cyclodextrin polyelectrolyte for the controlled release of drugs.

Carbohydrate polymers (2013-03-19)
Adeline Martin, Nicolas Tabary, Laurent Leclercq, Jatupol Junthip, Stéphanie Degoutin, François Aubert-Viard, Frédéric Cazaux, Joël Lyskawa, Ludovic Janus, Marc Bria, Bernard Martel
ABSTRACT

The aim of this work was to develop the formation of multilayered coating incorporating a cyclodextrin polyelectrolyte onto a non-woven polyethylene terephthalate (PET) textile support in order to obtain reservoir and sustained release properties towards bioactive molecules. We optimized the multilayer assembly immobilization onto the PET surface according to the layer-by-layer (LbL) deposition process. After a pre-treatment of the textile support aiming to offer a sufficient ionic character to the surface, it was alternatively immersed into two polyelectrolytes aqueous solutions consisting of chitosan (CHT) as polycation on the one hand, and a β-cyclodextrin polymer (polyCTR-βCD) as polyanion on the other hand. In a second approach, a TBBA/polyCTR-βCD complex (4-tert-butylbenzoic acid, TBBA) was used in order to load the system with a drug model whose kinetics of release was assessed. Gravimetry, microscopy, OWLS, colorimetric titration, infrared and zetametry were used as characterization techniques. An effective deposition on the textile surface due to ionic interactions with alternation of up to 10 layers of each of both polyelectrolytes was clearly evidenced. However, we observed that layer formation occurred to a lesser extent when TBBA/polyCTR-βCD complex was applied instead of polyCTR-βCD alone. The release study showed that drug reservoir properties and release kinetics could be controlled by the number of layers in the system and that TBBA release was faster than the multilayered coating degradation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-tert-Butylbenzoic acid, 99%